Bruker (BRKR) FCF Payout Ratio Growth (3y) (2019 - 2026)
Bruker (BRKR) FCF Payout Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Bruker | 8.25 Bn | 8.12 Bn | 379.80 Mn | 25.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.50% |
| Dec 31, 2025 | -12.51% |
| Sep 30, 2025 | -30.53% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 15.68% |
| Dec 31, 2024 | -67.60% |
| Sep 30, 2024 | -18.21% |
| Jun 30, 2024 | -26.78% |
| Mar 31, 2024 | 503.04% |
| Dec 31, 2023 | 6.21% |
| Sep 30, 2023 | 17.24% |
| Jun 30, 2023 | -27.00% |
| Mar 31, 2023 | -55.87% |
| Dec 31, 2022 | -1.99% |
| Sep 30, 2022 | 54.13% |
| Jun 30, 2022 | 47.90% |
| Mar 31, 2022 | -58.23% |
| Sep 30, 2021 | 74.61% |
| Jun 30, 2021 | 236.46% |
| Mar 31, 2021 | -22.46% |